Eero Vuorio

Eero Vuorio

Auto-generated profile, based on publicly available information

Eero Vuorio

University of Turku

Research Focus & Metrics

Academic Career Length

52Years (1975-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1987 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
MSM Sandberg
M Sandberg
EVE Vuorio
E Vuorio
Paraffin sections of human skeletal tissues were studied in order to identify cells responsible for production of types I, II, and III collagens by in situ hybridization. Northern hybridization and sequence information were used to select restriction fragments of cDNA clones for the corresponding mRNAs to obtain probes with a minimum of cross-hybridization. The specificity of the probes was proven in hybridizations to sections of developing fingers: osteoblasts and chondrocytes, known to produce only one type of fibrillar collagen each (I and II, respectively) were only recognized by the corresponding cDNA probes. Smooth connective tissues exhibited variable hybridization intensities with types I and III collagen cDNA probes. The technique was used to localize the activity of type II collagen production in the different zones of cartilage during the growth of long bones. Visual inspection and grain counting revealed the highest levels of pro alpha 1(II) collagen mRNAs in chondrocytes of the lower proliferative and upper hypertrophic zones of the growth plate cartilage. This finding was confirmed by Northern blotting of RNAs isolated from epiphyseal (resting) cartilage and from growth zone cartilage. Analysis of the osseochondral junction revealed virtually no overlap between hybridization patterns obtained with probes specific for type I and type II collagen mRNAs. Only a fraction of the chondrocytes in the degenerative zone were recognized by the pro alpha 1(II) collagen cDNA probe, and none by the type I collagen cDNA probe. In the mineralizing zone virtually all cells were recognized by the type I collagen cDNA probe, but only very few scattered cells appeared to contain type II collagen mRNA. These data indicate that in situ hybridization is a valuable tool for identification of connective tissue cells which are actively producing different types of collagens at the various stages of development, differentiation, and growth.

1 March 1997 in Developmental Dynamics
Verified
Journal Article
Open access
PDF file
NJNina Johansson
Nina Johansson
USUlpu Saarialho-Kere
Ulpu Saarialho-Kere
KAKristiina Airola
Kristiina Airola
RHRiitta Herva
Riitta Herva
LNLiisa Nissinen
Liisa Nissinen
Veli-Matti KähäriVeli-Matti Kähäri
Veli-Matti Kähäri
Collagenase-3 (MMP-13) is a novel matrix metalloproteinase, the expression of which has so far only been documented in human breast carcinomas and osteoarthritic cartilage. In this study we have examined the expression of MMP-13 during human fetal development. Northern blot hybridizations revealed abundant expression of MMP-13 mRNAs in total RNA from fetal cartilage and calvaria at gestational age of 15 weeks. By in situ hybridization MMP-13 transcripts were detected in chondrocytes of hypertrophic cartilage in vertebrae of the spinal column and in the dorsal end of ribs undergoing ossification, as well as in osteoblasts and periosteal cells below the inner periosteal region of ossified ribs. In contrast, no expression of MMP-13 could be detected in osteoclasts. Furthermore, expression of MMP-13 mRNA was detected in osteoblasts and fibroblasts primarily on the inner side of calvarial bone of the skull at 16 weeks of gestation. Expression of MMP-13 mRNA by primary human fetal chondrocytes in culture was enhanced by transforming growth factor-β (TGF-β) and inhibited by bone morphogenetic protein-2 (BMP-2). No expression of MMP-13 mRNA could be noted in other fetal tissues, including the skin, lungs, neural tissue, muscle, and liver. These results suggest that MMP-13 plays an important role in the extracellular matrix remodeling during fetal bone development both via endochondral and intramembranous ossification. Dev. Dyn. 208:387–395, 1997.

16 January 2013 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
SLSutada Lotinun
Sutada Lotinun
RKRiku Kiviranta
Riku Kiviranta
TMTakuma Matsubara
Takuma Matsubara
JAJorge A. Alzate
Jorge A. Alzate
LNLynn Neff
Lynn Neff
RBRoland Baron
Roland Baron
Cathepsin K (CTSK) is secreted by osteoclasts to degrade collagen and other matrix proteins during bone resorption. Global deletion of Ctsk in mice decreases bone resorption, leading to osteopetrosis, but also increases the bone formation rate (BFR). To understand how Ctsk deletion increases the BFR, we generated osteoclast- and osteoblast-targeted Ctsk knockout mice using floxed Ctsk alleles. Targeted ablation of Ctsk in hematopoietic cells, or specifically in osteoclasts and cells of the monocyte-osteoclast lineage, resulted in increased bone volume and BFR as well as osteoclast and osteoblast numbers. In contrast, targeted deletion of Ctsk in osteoblasts had no effect on bone resorption or BFR, demonstrating that the increased BFR is osteoclast dependent. Deletion of Ctsk in osteoclasts increased their sphingosine kinase 1 (Sphk1) expression. Conditioned media from Ctsk-deficient osteoclasts, which contained elevated levels of sphingosine-1-phosphate (S1P), increased alkaline phosphatase and mineralized nodules in osteoblast cultures. An S1P1,3 receptor antagonist inhibited these responses. Osteoblasts derived from mice with Ctsk-deficient osteoclasts had an increased RANKL/OPG ratio, providing a positive feedback loop that increased the number of osteoclasts. Our data provide genetic evidence that deletion of CTSK in osteoclasts enhances bone formation in vivo by increasing the generation of osteoclast-derived S1P.

1 August 1994 in Matrix Biology
Verified
Journal Article
Closed access
VLVéronique Lefebvre
Véronique Lefebvre
SGSilvio Garofalo
Silvio Garofalo
GZGuang Zhou
Guang Zhou
MMMarjo Metsäranta
Marjo Metsäranta
EVEero Vuorio
Eero Vuorio
BCBenoit De Crombrugghe
Benoit De Crombrugghe

1 March 1993 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
AHAri Hiltunen
Ari Hiltunen
EVEero Vuorio
Eero Vuorio
HAHannu Aro
Hannu Aro

1 May 1988 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
Veli-Matti KähäriVeli-Matti Kähäri
Veli-Matti Kähäri
MSMinna. Sandberg
Minna. Sandberg
HKHannu. Kalimo
Hannu. Kalimo
TVTuula. Vuorio
Tuula. Vuorio
EVEero. Vuorio
Eero. Vuorio